Codexis Inc (CDXS)
Codexis stock today
Codexis closed at $1.19 on October 30, 2026, down 2.46% on the day. Over the past year it returned -49.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $108 million.
| Period | CDXS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -14.4% | -0.9% |
| 3 months | -19.6% | +2.1% |
| Year to date | -27.0% | +11.7% |
| 1 year | -49.6% | +12.4% |
| 3 years | -22.7% | +88.5% |
| 5 years | -96.6% | +76.0% |
Key statistics
- Market value
- $108M
- Price / sales
- 1.4
- 52-week range
- $0.98 to $2.85
- Next report
- Nov 12, 2026
About Codexis
Develops and manufactures engineered proteins and biocatalysts for pharmaceutical, chemical, and food applications.
Sector: Health Care
More on Codexis
- Financials: revenue, earnings and segmentsRevenue +19% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $264.44 today
No forecast, no recommendation. This page describes Codexis Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.